These Four Stocks Are Leading Today’s Losers Pack for Various Reasons

Investors are not happy with AMAYA INC (NASDAQ:AYA)‘s latest financial report, driving the stock lower by as much as 35% so far today. A Canadian provider of products and services for the gaming and entertainment industries, Amaya has posted revenues of CAD 324 ($244) million, up by 8.4% year-over-year, and a profit of CAD 0.44 ($0.33) per share, which is in line with analysts’ expectations. What really drove the stock lower this morning was the revision of its forward guidance. The company has lowered 2015 full year estimates to earnings in the range of CAD 1.66 to CAD 1.75 ($1.25-$1.32) and revenues of CAD 1.29 to CAD 1.34 ($0.97-$1.01) billion. The management has stated that currency swings is the main reason behind this downward revision, while delays in the rollout of upgrades to some of the company’s products are also expected to have an impact on revenues.

Whereas none of the funds we follow were invested in AMAYA INC (NASDAQ:AYA) at the end of March, 19 funds held more than 20% of the common stock at the end of the second quarter. Frank Brosens was among those impressed by the prospects of Amaya, having built a position that amassed 1.06 million shares at the end of June. Kieran Goodwin, the manager of Panning Capital Management, is also bullish, having bought some 1.55 million shares during the second quarter.

Topping the Wall Street’s earnings expectations did not stop Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) from sliding this morning, with the stock currently down by more than 23%. The company registered net sales of $67.3 million, up by 54% compared to the third quarter of 2014, and a loss of $0.34 per share. When adjusted for amortization costs and costs related to mergers and acquisitions, Aegerion actually registered a profit of $0.20 per share. So far this year, the stock has lost more than 54% of its value and is currently trading around the $10 level.

Hedge funds have a significant presence in the Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) shareholders’ ranks, as 16 funds held roughly 49% of outstanding shares at the end of June, with their positions valued at $266 million. Scopia Capital, run by Matt Sirovich and Jeremy Mindich, held the largest stake in the company among the funds we follow, having reported ownership of 5.42 million shares in its latest 13F filing. Kevin Kotler is also betting big on Aegerion, with his fund, Broadfin Capital, holding 2.85 million shares at the end of June.

Disclosure: none.